Investors Urged to Join Class Action Against LifeMD, Inc. Over Securities Fraud Allegations
Class Action Lawsuit Filed Against LifeMD, Inc.
Overview
In a significant legal development, Pomerantz LLP has initiated a class action lawsuit aimed at LifeMD, Inc. (NASDAQ: LFMD). This lawsuit primarily addresses allegations regarding securities fraud and other questionable business practices conducted by the company and some of its top officials. Investors who incurred losses during the class period are encouraged to seek participation in this lawsuit before the impending deadlines.
Key Details
Specifically, the lawsuit revolves around whether LifeMD's actions constituted securities fraud. Investors who purchased or acquired LifeMD securities during the specified class period can apply to be designated as Lead Plaintiffs. The deadline to make such requests is October 27, 2025. Interested investors can also retrieve a copy of the complaint from Pomerantz’s official website.
Background of the Case
On August 5, 2025, LifeMD reported its second-quarter financial results, causing a stir in the market. During the earnings call, CFO Marc Benathen acknowledged some
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.